<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Infect Dis</journal-id><journal-id journal-id-type="iso-abbrev">BMC Infect Dis</journal-id><journal-title-group><journal-title>BMC Infectious Diseases</journal-title></journal-title-group><issn pub-type="epub">1471-2334</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39905298</article-id><article-id pub-id-type="pmc">PMC11795989</article-id>
<article-id pub-id-type="publisher-id">10540</article-id><article-id pub-id-type="doi">10.1186/s12879-025-10540-2</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Regional differences in triage decisions affect hospital mortality among frail COVID-19 patients in the COvid MEdicaTion study</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" equal-contrib="yes"><name><surname>Minnema</surname><given-names>Julia</given-names></name><address><email>j.minnema@erasmusmc.nl</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Sablerolles</surname><given-names>Roos</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>van Kempen</surname><given-names>Janneke</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>van der Kuy</surname><given-names>Hugo</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Polinder-Bos</surname><given-names>Harmke</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>van de Loo</surname><given-names>Bob</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Versmissen</surname><given-names>Jorie</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Haaksma</surname><given-names>Miriam L.</given-names></name><xref ref-type="aff" rid="Aff5">5</xref><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Lafeber</surname><given-names>Melvin</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Faes</surname><given-names>Miriam C.</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><collab>on behalf of the COMET research team^<contrib-group><contrib contrib-type="author"><name><surname>Minnema</surname><given-names>Julia</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Sablerolles</surname><given-names>Roos</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>van Kempen</surname><given-names>Janneke</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>van der Kuy</surname><given-names>Hugo</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Polinder-Bos</surname><given-names>Harmke</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>van de Loo</surname><given-names>Bob</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Versmissen</surname><given-names>Jorie</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Lafeber</surname><given-names>Melvin</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Faes</surname><given-names>Miriam C.</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>van Haelst</surname><given-names>Ingrid</given-names></name><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><name><surname>Andrews</surname><given-names>Louise</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name><surname>Kemper</surname><given-names>Marleen</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>van den Berg</surname><given-names>Roland</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Slob</surname><given-names>Elise</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Boutkourt</surname><given-names>Firdaouss</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><name><surname>van Kan</surname><given-names>Erik</given-names></name><xref ref-type="aff" rid="Aff11">11</xref></contrib><contrib contrib-type="author"><name><surname>Van Etten</surname><given-names>Ronald</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Kappers</surname><given-names>Mariette</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>van Wijngaarden</surname><given-names>Peter</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Vos</surname><given-names>Anja</given-names></name><xref ref-type="aff" rid="Aff12">12</xref></contrib><contrib contrib-type="author"><name><surname>Hendriksen</surname><given-names>Linda</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><name><surname>de Wit</surname><given-names>Hugo</given-names></name><xref ref-type="aff" rid="Aff14">14</xref></contrib><contrib contrib-type="author"><name><surname>Visser</surname><given-names>Loes</given-names></name><xref ref-type="aff" rid="Aff15">15</xref></contrib><contrib contrib-type="author"><name><surname>Derijks</surname><given-names>Judith</given-names></name><xref ref-type="aff" rid="Aff16">16</xref></contrib><contrib contrib-type="author"><name><surname>Haider</surname><given-names>Doris</given-names></name><xref ref-type="aff" rid="Aff17">17</xref></contrib><contrib contrib-type="author"><name><surname>Lindner</surname><given-names>Nikolaus</given-names></name><xref ref-type="aff" rid="Aff18">18</xref></contrib><contrib contrib-type="author"><name><surname>Schwap</surname><given-names>Monika</given-names></name><xref ref-type="aff" rid="Aff19">19</xref></contrib><contrib contrib-type="author"><name><surname>Tournoy</surname><given-names>Jos</given-names></name><xref ref-type="aff" rid="Aff18">18</xref></contrib><contrib contrib-type="author"><name><surname>Van der Linden</surname><given-names>Lorenz</given-names></name><xref ref-type="aff" rid="Aff18">18</xref></contrib><contrib contrib-type="author"><name><surname>Houlind</surname><given-names>Morten Baltzer</given-names></name><xref ref-type="aff" rid="Aff19">19</xref></contrib><contrib contrib-type="author"><name><surname>Tessari</surname><given-names>Roberto</given-names></name><xref ref-type="aff" rid="Aff20">20</xref></contrib><contrib contrib-type="author"><name><surname>Chessa</surname><given-names>Paola</given-names></name><xref ref-type="aff" rid="Aff21">21</xref></contrib><contrib contrib-type="author"><name><surname>Gambera</surname><given-names>Marco</given-names></name><xref ref-type="aff" rid="Aff22">22</xref></contrib><contrib contrib-type="author"><name><surname>Martignoni</surname><given-names>Isabella</given-names></name><xref ref-type="aff" rid="Aff22">22</xref></contrib><contrib contrib-type="author"><name><surname>Agnoletto</surname><given-names>Laura</given-names></name><xref ref-type="aff" rid="Aff23">23</xref></contrib><contrib contrib-type="author"><name><surname>Falcao</surname><given-names>Margarida</given-names></name><xref ref-type="aff" rid="Aff24">24</xref></contrib><contrib contrib-type="author"><name><surname>Farinha</surname><given-names>Helena</given-names></name><xref ref-type="aff" rid="Aff24">24</xref></contrib><contrib contrib-type="author"><name><surname>Mendes</surname><given-names>Dina</given-names></name><xref ref-type="aff" rid="Aff24">24</xref></contrib><contrib contrib-type="author"><name><surname>Carmo</surname><given-names>Ines</given-names></name><xref ref-type="aff" rid="Aff24">24</xref></contrib><contrib contrib-type="author"><name><surname>Soares</surname><given-names>Joana</given-names></name><xref ref-type="aff" rid="Aff25">25</xref></contrib><contrib contrib-type="author"><name><surname>Falcao</surname><given-names>Fatima</given-names></name><xref ref-type="aff" rid="Aff25">25</xref></contrib><contrib contrib-type="author"><name><surname>Solano</surname><given-names>Mariana</given-names></name><xref ref-type="aff" rid="Aff25">25</xref></contrib><contrib contrib-type="author"><name><surname>Viegas</surname><given-names>Erica</given-names></name><xref ref-type="aff" rid="Aff25">25</xref></contrib><contrib contrib-type="author"><name><surname>Miarons</surname><given-names>Marta</given-names></name><xref ref-type="aff" rid="Aff26">26</xref></contrib><contrib contrib-type="author"><name><surname>Gorgas</surname><given-names>Maria Queralt</given-names></name><xref ref-type="aff" rid="Aff26">26</xref></contrib><contrib contrib-type="author"><name><surname>Yubero</surname><given-names>Cristina Garc&#x000ed;a</given-names></name><xref ref-type="aff" rid="Aff27">27</xref></contrib><contrib contrib-type="author"><name><surname>Blum</surname><given-names>Kim</given-names></name><xref ref-type="aff" rid="Aff28">28</xref></contrib><contrib contrib-type="author"><name><surname>Keijzers</surname><given-names>Kim</given-names></name><xref ref-type="aff" rid="Aff29">29</xref></contrib><contrib contrib-type="author"><name><surname>Lim</surname><given-names>Silke</given-names></name><xref ref-type="aff" rid="Aff29">29</xref></contrib></contrib-group></collab></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/018906e22</institution-id><institution-id institution-id-type="GRID">grid.5645.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 0459 992X</institution-id><institution>Department of Internal Medicine, Erasmus MC, </institution><institution>University Medical Center Rotterdam, </institution></institution-wrap>Rotterdam, the Netherlands </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/018906e22</institution-id><institution-id institution-id-type="GRID">grid.5645.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 0459 992X</institution-id><institution>Department of Hospital Pharmacy, Erasmus MC, </institution><institution>University Medical Center Rotterdam, </institution></institution-wrap>Rotterdam, the Netherlands </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01g21pa45</institution-id><institution-id institution-id-type="GRID">grid.413711.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 4687 1426</institution-id><institution>Department of Geriatrics, </institution><institution>Amphia Hospital, </institution></institution-wrap>Breda, the Netherlands </aff><aff id="Aff4"><label>4</label>Digitalis Rx BV, Amsterdam, the Netherlands </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05xvt9f17</institution-id><institution-id institution-id-type="GRID">grid.10419.3d</institution-id><institution-id institution-id-type="ISNI">0000000089452978</institution-id><institution>Department of Public Health and Primary Care, </institution><institution>Leiden University Medical Centre, </institution></institution-wrap>Leiden, The Netherlands </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05xvt9f17</institution-id><institution-id institution-id-type="GRID">grid.10419.3d</institution-id><institution-id institution-id-type="ISNI">0000 0000 8945 2978</institution-id><institution>University Network for the Care sector South-Holland, Leiden University Medical Center, </institution></institution-wrap>Leiden, The Netherlands </aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00bc64s87</institution-id><institution-id institution-id-type="GRID">grid.491364.d</institution-id><institution>Noordwest Ziekenhuisgroep, </institution></institution-wrap>Alkmaar, the Netherlands </aff><aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04n1xa154</institution-id><institution-id institution-id-type="GRID">grid.414725.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 0368 8146</institution-id><institution>Meander MC, </institution></institution-wrap>Amersfoort, the Netherlands </aff><aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05grdyy37</institution-id><institution-id institution-id-type="GRID">grid.509540.d</institution-id><institution-id institution-id-type="ISNI">0000 0004 6880 3010</institution-id><institution>Amsterdam UMC, AMC, </institution></institution-wrap>Amsterdam, the Netherlands </aff><aff id="Aff10"><label>10</label>Farmadam Apotheek, Amsterdam, the Netherlands </aff><aff id="Aff11"><label>11</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05275vm15</institution-id><institution-id institution-id-type="GRID">grid.415355.3</institution-id><institution-id institution-id-type="ISNI">0000 0004 0370 4214</institution-id><institution>Gelre ziekenhuizen, </institution></institution-wrap>Apeldoorn/Zutphen, the Netherlands </aff><aff id="Aff12"><label>12</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01tm5k604</institution-id><institution-id institution-id-type="GRID">grid.491363.a</institution-id><institution-id institution-id-type="ISNI">0000 0004 5345 9413</institution-id><institution>Treant Zorggroep, </institution></institution-wrap>Emmen, the Netherlands </aff><aff id="Aff13"><label>13</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/045nawc23</institution-id><institution-id institution-id-type="GRID">grid.413202.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 0626 2490</institution-id><institution>Tergooi hospital, </institution></institution-wrap>Hilversum, the Netherlands </aff><aff id="Aff14"><label>14</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/027vts844</institution-id><institution-id institution-id-type="GRID">grid.413327.0</institution-id><institution-id institution-id-type="ISNI">0000 0004 0444 9008</institution-id><institution>Canisius Wilhelmina Hospital, </institution></institution-wrap>Nijmegen, the Netherlands </aff><aff id="Aff15"><label>15</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03q4p1y48</institution-id><institution-id institution-id-type="GRID">grid.413591.b</institution-id><institution-id institution-id-type="ISNI">0000 0004 0568 6689</institution-id><institution>Haga Ziekenhuis, </institution></institution-wrap>Den Haag, the Netherlands </aff><aff id="Aff16"><label>16</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05wg1m734</institution-id><institution-id institution-id-type="GRID">grid.10417.33</institution-id><institution-id institution-id-type="ISNI">0000 0004 0444 9382</institution-id><institution>Radboud UMC, </institution></institution-wrap>Nijmegen, the Netherlands </aff><aff id="Aff17"><label>17</label>Klinik Favoriten, Vienna, Austria </aff><aff id="Aff18"><label>18</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/0424bsv16</institution-id><institution-id institution-id-type="GRID">grid.410569.f</institution-id><institution-id institution-id-type="ISNI">0000 0004 0626 3338</institution-id><institution>University Hospitals Leuven, </institution></institution-wrap>Leuven, Belgium </aff><aff id="Aff19"><label>19</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05bpbnx46</institution-id><institution-id institution-id-type="GRID">grid.4973.9</institution-id><institution-id institution-id-type="ISNI">0000 0004 0646 7373</institution-id><institution>Copenhagen University Hospital Amager and Hvidovre, </institution></institution-wrap>Copenhagen, Denmark </aff><aff id="Aff20"><label>20</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/010hq5p48</institution-id><institution-id institution-id-type="GRID">grid.416422.7</institution-id><institution-id institution-id-type="ISNI">0000 0004 1760 2489</institution-id><institution>IRCCS Ospedale Sacro Cuore Don Calabria, </institution></institution-wrap>Negrar di Valpolicella, Italy </aff><aff id="Aff21"><label>21</label>San Francesco Hospital Nuoro, Nuoro, Italy </aff><aff id="Aff22"><label>22</label><institution-wrap><institution-id institution-id-type="GRID">grid.513352.3</institution-id><institution>Pederzoli Hospital, </institution></institution-wrap>Peschiera del Garda, VR Italy </aff><aff id="Aff23"><label>23</label>Azienda Ulss 5 Veneto, Rovigo, Italy </aff><aff id="Aff24"><label>24</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/012habm93</institution-id><institution-id institution-id-type="GRID">grid.414462.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 1009 677X</institution-id><institution>Egas Moniz Hospital, </institution></institution-wrap>Lisboa, Portugal </aff><aff id="Aff25"><label>25</label>Hospital S&#x000e3;o Francisco Xavier, Lisboa, Portugal </aff><aff id="Aff26"><label>26</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03ba28x55</institution-id><institution-id institution-id-type="GRID">grid.411083.f</institution-id><institution-id institution-id-type="ISNI">0000 0001 0675 8654</institution-id><institution>Vall d&#x02019;Hebron Hospital, </institution></institution-wrap>Barcelona, Spain </aff><aff id="Aff27"><label>27</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05dfzd836</institution-id><institution-id institution-id-type="GRID">grid.414758.b</institution-id><institution-id institution-id-type="ISNI">0000 0004 1759 6533</institution-id><institution>University Hospital Infanta Sof&#x000ed;a, </institution></institution-wrap>San Sebasti&#x000e1;n de los Reyes, Spain </aff><aff id="Aff28"><label>28</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/056tb3809</institution-id><institution-id institution-id-type="GRID">grid.413357.7</institution-id><institution-id institution-id-type="ISNI">0000 0000 8704 3732</institution-id><institution>FHP Kantonsspital Aarau, </institution></institution-wrap>Aarau, Switzerland </aff><aff id="Aff29"><label>29</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02zk3am42</institution-id><institution-id institution-id-type="GRID">grid.413354.4</institution-id><institution-id institution-id-type="ISNI">0000 0000 8587 8621</institution-id><institution>Cantonal Hospital of Lucerne, </institution></institution-wrap>Lucerne, Switzerland </aff></contrib-group><pub-date pub-type="epub"><day>4</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>4</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>25</volume><elocation-id>165</elocation-id><history><date date-type="received"><day>2</day><month>5</month><year>2024</year></date><date date-type="accepted"><day>22</day><month>1</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2025, corrected publication 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><sec><title>Objectives</title><p id="Par1">The scarcity of intensive care unit (ICU) beds during the COVID-19 pandemic has led to a large number of national and international guidelines for the triage of ICU admission. Regional variation in medical decision making might affect ICU triage decisions. We investigate whether regional differences in ICU admission, as surrogate for triage decisions, affect in-hospital mortality in COVID-19 patients.</p></sec><sec><title>Methods</title><p id="Par2">The COMET study is a multicenter, observational cohort study, including adult patients hospitalized for COVID-19 between March 2020&#x02013; July 2020. Patients&#x02019; characteristics, prescribed medication, clinical characteristics, and CFS were collected. Patients from 11 European countries were included and these countries were categorized into two regions: north and south. The effects of region on ICU admission and in-hospital mortality were assessed using logistic regression analyses stratified for frailty.</p></sec><sec><title>Results</title><p id="Par3">Frail patients had a higher risk for ICU admission in southern compared to northern countries (OR: 1.64; 95%CI: 1.10&#x02013;2.46), whereas fit patients had a similar risk for ICU admission in southern compared to northern countries (OR: 0.75; 95%CI: 0.55&#x02013;1.01). There was no difference in in-hospital mortality between northern and southern countries for fit and frail patients (respectively OR: 0.82; 95% CI 0.52&#x02013;1.29, and OR: 1.11; 95% CI: 0.74&#x02013;1.66).</p></sec><sec><title>Conclusion</title><p id="Par4">Our study shows that, despite variation in rates of ICU admission between northern and southern countries for frail patients, no difference in in-hospital mortality was observed. This might help optimize prioritization of resources in a pandemic setting while offering options for palliative care instead of ICU admission.</p></sec><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1186/s12879-025-10540-2.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>COVID-19</kwd><kwd>Frailty</kwd><kwd>Triage</kwd><kwd>Policy</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001826</institution-id><institution>ZonMw</institution></institution-wrap></funding-source><award-id>10430102110005</award-id><award-id>10430102110005</award-id><award-id>10430102110005</award-id><award-id>10430102110005</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution>LOEY Foundation</institution></funding-source></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; BioMed Central Ltd., part of Springer Nature 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par5">During the first wave of the COVID-19 pandemic, scarce hospital resources raised ethical dilemmas about triage decisions, predominantly for admission to the intensive care unit (ICU). In most countries, hospitals were overcrowded and largely unprepared for the high number of COVID-19 referrals and ICU admissions. European countries differ in ICU policies regarding number of ICU beds per head of population but also in medical decision making to determine who to admit to the ICU [<xref ref-type="bibr" rid="CR1">1</xref>]. The aim of triage is to utilize scarce resources effectively and efficiently. To prioritize ICU admission, guidelines were created to support bedside decision making for the triage of COVID-19 patients [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. All European triage guidelines share a common principle of maximizing the benefit of available resources, although the operationalization varies per country.</p><p id="Par6">Prior to the COVID-19 pandemic, it was recognized that regional variations exist in end-of-life practices within the ICU, which may be attributed to social, religious and/or legal reasons [<xref ref-type="bibr" rid="CR4">4</xref>]. Following the COVID-19 pandemic, a multicenter, prospective study, including 3105 critically ill patients aged 70 years and older within the ICU in Europe, observed that there is a gradient in rates of treatment limitation from north to south [<xref ref-type="bibr" rid="CR5">5</xref>]. In Northern European countries, the highest frequency of treatment limitation was reported (48%), followed by Central European countries (39%), and the lowest rates were seen in Southern European countries (24%). This gradient reflects a decreasing incidence of withholding and withdrawing treatment from north to south. Considerations to decline ICU admission are in general a poor prognosis based on patient characteristics such as age, pre-existing comorbidities, and/or acute organ failure [<xref ref-type="bibr" rid="CR5">5</xref>]. Throughout the pandemic, explicit consideration of frailty has become more common through the use of the Clinical Frailty Scale (CFS) [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. In addition, differences in triage guidelines between northern and southern European countries influence decisions regarding ICU admission. For instance, in case of a shortage in ICU beds, policymakers in the Netherlands argue that it is justifiable to, after an assessment based on prognosis and chance of survival, evaluate patient priority for ICU admission based on the expected length of stay on the ICU [<xref ref-type="bibr" rid="CR2">2</xref>]. Conversely, this factor is not described in other European guidelines as part of any triage rule. In this study, we aim to assess whether regional differences in ICU admission, as surrogate for triage decisions, affect in-hospital mortality in COVID-19 patients.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Study design and participants</title><p id="Par7">The COMET study is an observational, retrospective cohort study conducted during the initial wave of the COVID-19 pandemic (March&#x02013; July 2020). The study included patients&#x02009;&#x02265;&#x02009;18 years who had a high clinical likelihood of COVID-19 based on clinical, biochemical and/ or radiological criteria or tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and were subsequently admitted to the hospital. The rationale and design of the COMET study have previously been described [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. In this post-hoc analysis of the COMET study, patients with available CFS score coming from 63 centers in 11 European countries were included. These countries were categorized into two regions: north (Austria, Belgium, Switzerland, Germany, Denmark, Great Britain, the Netherlands, and France) and south (Italy, Portugal and Spain). The differentiation between northern and southern countries in our analysis was based on geographical location and supported by findings from previous studies highlighting significant regional differences in medical decision-making, particularly regarding treatment limitation at the ICU [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. The members of the COMET research group are listed in Supplemental List <xref rid="MOESM1" ref-type="media">1</xref>. The Erasmus Medical Center Medical Ethics Review Committee in Rotterdam, the Netherlands, approved the study (MEC-2020-0277), and each institutional review board of the participating hospitals approved the use of data, as described in the protocol [<xref ref-type="bibr" rid="CR8">8</xref>].</p></sec><sec id="Sec4"><title>Data collection</title><p id="Par8">Data collection included prescribed medication, patient characteristics at admission i.e. the clinical frailty scale (CFS), and clinical outcomes such as ICU admission and in-hospital mortality [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. To ensure a consistent definition of ICU beds across the participating centers, we verified whether their ICU beds adhered to a standardized definition, which defines ICU beds as &#x02018;beds with critical care equipment (e.g., ventilator) that are adequately staffed by specialized nurses and physicians with critical care training&#x02019; [<xref ref-type="bibr" rid="CR11">11</xref>]. Data were retrospectively collected from the electronic medical records in an online database (Clinical Rules reporter, version 1.6.3; Digitalis Rx, Amsterdam, the Netherlands) and pseudonymized.</p></sec><sec id="Sec5"><title>Statistical analysis</title><p id="Par9">The effect of region on ICU admission and in-hospital mortality were assessed using logistic regression analyses stratified for frailty (fit: CFS 1&#x02013;3, mildly frail: CFS 4&#x02013;5, frail: CFS 6&#x02013;9). Two different models were built.</p><p id="Par10">
<list list-type="bullet"><list-item><p id="Par11">Model 1: A crude, unadjusted estimate for region.</p></list-item><list-item><p id="Par12">Model 2: Model 1 and an additional adjustment for age and sex.</p></list-item></list>
</p><p id="Par13">Sensitivity analyses were performed in which we adjusted the classification of region. Since the allocation of central European countries (Austria, Switzerland, Germany and France) is considered arbitrary, we have assigned them to the southern countries in the sensitivity analyses, whereas they are classified as northern countries in the primary analyses [<xref ref-type="bibr" rid="CR5">5</xref>].</p></sec></sec><sec id="Sec6"><title>Results</title><p id="Par14">Data were collected for 2434 patients &#x02265;18 years included in 63 centers in 11 European countries (North: Austria <italic>n</italic>&#x02009;=&#x02009;447, Belgium <italic>n</italic>&#x02009;=&#x02009;46, Switzerland <italic>n</italic>&#x02009;=&#x02009;91, Germany <italic>n</italic>&#x02009;=&#x02009;12, Denmark <italic>n</italic>&#x02009;=&#x02009;30, Great Britain <italic>n</italic>&#x02009;=&#x02009;53, the Netherlands <italic>n</italic>&#x02009;=&#x02009;1030, France <italic>n</italic>&#x02009;=&#x02009;71; South: Italy <italic>n</italic>&#x02009;=&#x02009;327, Portugal <italic>n</italic>&#x02009;=&#x02009;148, Spain <italic>n</italic>&#x02009;=&#x02009;179).</p><p id="Par15">Baseline characteristics for patients in northern and southern countries were compared in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>. Patients in the northern and southern countries were of similar age (resp. mean 67 [IQR 55&#x02013;77] vs. mean 68 [IQR 56&#x02013;78]) and used a similar number of prescribed drugs (resp. mean 3 [IQR 1&#x02013;7] vs. mean 3 [IQR 1&#x02013;6).</p><p id="Par16">
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Characteristics for patients in northern and southern countries (<italic>n</italic>&#x02009;=&#x02009;2434)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Total (<italic>n</italic>&#x02009;=&#x02009;2434)</th><th align="left">North (<italic>n</italic>&#x02009;=&#x02009;1780)</th><th align="left">South (<italic>n</italic>&#x02009;=&#x02009;654)</th></tr></thead><tbody><tr><td align="left">
<bold>Patient characteristics</bold>
</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Age (years), median [IQR]</td><td align="left">67 (55&#x02013;77)</td><td align="left">67 (55&#x02013;77)</td><td align="left">68 (56&#x02013;78)</td></tr><tr><td align="left">Men, n (%)</td><td align="left">1480 (60.8)</td><td align="left">1094 (61.5)</td><td align="left">386 (59.0)</td></tr><tr><td align="left">BMI, n (%)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Normal</td><td align="left">798 (41.2)</td><td align="left">543 (36.5)</td><td align="left">255 (56.4)</td></tr><tr><td align="left">Pre-obesity</td><td align="left">564 (29.1)</td><td align="left">469 (31.5)</td><td align="left">95 (21.0)</td></tr><tr><td align="left">Obesity</td><td align="left">577 (29.8)</td><td align="left">475 (31.9)</td><td align="left">102 (22.6)</td></tr><tr><td align="left">Frailty, n (%)</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Fit (CFS 1&#x02013;3)</td><td align="left">1377 (56.6)</td><td align="left">1043 (58.6)</td><td align="left">334 (51.1)</td></tr><tr><td align="left">Mildly frail (CFS 4&#x02013;5)</td><td align="left">564 (23.2)</td><td align="left">428 (24.0)</td><td align="left">136 (20.8)</td></tr><tr><td align="left">Frail (CFS 6&#x02013;9)</td><td align="left">493 (20.3)</td><td align="left">309 (17.4)</td><td align="left">184 (28.1)</td></tr><tr><td align="left">
<bold>Use of medication pre-admission</bold>
</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Blood pressure-lowering drugs, n (%)</td><td align="left">1136 (53.3)</td><td align="left">790 (44.4)</td><td align="left">346 (52.9)</td></tr><tr><td align="left">Antiplatelet drugs, n (%)</td><td align="left">405 (16.6)</td><td align="left">297 (16.7)</td><td align="left">108 (16.5)</td></tr><tr><td align="left">Oral anticoagulant drugs, n (%)</td><td align="left">272 (11.2)</td><td align="left">223 (12.5)</td><td align="left">49 (7.5)</td></tr><tr><td align="left">Glucose-lowering drugs, n (%)</td><td align="left">437 (18.0)</td><td align="left">318 (17.9)</td><td align="left">119 (18.2)</td></tr><tr><td align="left">Antipsychotic drugs and cholinesterase inhibitors, n (%)</td><td align="left">143 (5.9)</td><td align="left">85 (4.8)</td><td align="left">58 (8.9)</td></tr><tr><td align="left">Number of prescribed drugs, mean [IQR]</td><td align="left">3 (1&#x02013;7)</td><td align="left">3 (1&#x02013;7)</td><td align="left">3 (1&#x02013;6)</td></tr><tr><td align="left">
<bold>In-hospital outcomes</bold>
</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Intensive care admission, n (%)</td><td align="left">616 (25.3)</td><td align="left">454 (25.5)</td><td align="left">162 (24.8)</td></tr><tr><td align="left">In-hospital mortality, n (%)</td><td align="left">456 (18.7)</td><td align="left">343 (19.3)</td><td align="left">113 (17.3)</td></tr></tbody></table><table-wrap-foot><p>Legend: North: Austria, Belgium, Switzerland, Germany, Denmark, Great Britain, the Netherlands, France; South: Italy, Portugal, Spain</p><p>Non-available values: Total: 495 BMI; North: 293 BMI; South: 202 BMI</p></table-wrap-foot></table-wrap>
</p><p id="Par17">The association between region and ICU admission stratified for frailty score is shown in Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>. After adjustments of covariates (model 2), frail patients had a higher risk for ICU admission in southern compared to northern countries (OR: 1.64 (95% CI: 1.10&#x02013;2.46)). Fit patients had similar risk for ICU admission in southern compared to northern countries (OR: 0.75 (95% CI: 0.55&#x02013;1.01)), although this was borderline. For mildly frail patients, also no difference was observed in the risk for ICU admission between northern and southern countries (OR: 0.86 (95% CI: 0.51&#x02013;1.46)).</p><p id="Par18">
<table-wrap id="Tab2"><label>Table 2</label><caption><p>Logistic regression analysis for region and respectively ICU admission and in-hospital mortality</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="2"/><th align="left">ICU admission</th><th align="left">In-hospital mortality</th></tr><tr><th align="left"/><th align="left">North</th><th align="left">South<break/>OR (95% CI)</th><th align="left">South<break/>OR (95% CI)</th></tr></thead><tbody><tr><td align="left">
<bold>Fit (CFS 1&#x02013;3) (</bold>
<italic>n</italic>
<bold>&#x02009;=&#x02009;1377)</bold>
</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Model 1: crude analysis</td><td align="left">Ref.</td><td char="." align="char">0.71 (0.53&#x02013;0.96)</td><td align="left">0.71 (0.46&#x02013;1.10)</td></tr><tr><td align="left">Model 2: model 1&#x02009;+&#x02009;adjusted for age and sex</td><td align="left">Ref.</td><td char="." align="char">0.75 (0.55&#x02013;1.01)</td><td align="left">0.82 (0.52&#x02013;1.29)</td></tr><tr><td align="left">
<bold>Mildly frail (CFS 4&#x02013;5) (</bold>
<italic>n</italic>
<bold>&#x02009;=&#x02009;564)</bold>
</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Model 1: crude analysis</td><td align="left">Ref.</td><td char="." align="char">0.82 (0.49&#x02013;1.36)</td><td align="left">0.25 (0.13&#x02013;0.47)</td></tr><tr><td align="left">Model 2: model 1&#x02009;+&#x02009;adjusted for age and sex</td><td align="left">Ref.</td><td char="." align="char">0.86 (0.51&#x02013;1.46)</td><td align="left">0.16 (0.08&#x02013;0.33)</td></tr><tr><td align="left">
<bold>Frail (CFS 6&#x02013;9) (</bold>
<italic>n</italic>
<bold>&#x02009;=&#x02009;493)</bold>
</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Model 1: crude analysis</td><td align="left">Ref.</td><td char="." align="char">1.52 (1.03&#x02013;2.23)</td><td align="left">1.25 (0.86&#x02013;1.82)</td></tr><tr><td align="left">Model 2: model 1&#x02009;+&#x02009;adjusted for age and sex</td><td align="left">Ref.</td><td char="." align="char">1.64 (1.10&#x02013;2.46)</td><td align="left">1.11 (0.74&#x02013;1.66)</td></tr></tbody></table><table-wrap-foot><p>Abbreviations: OR, odds ratio; CI, confidence interval; North: Austria, Belgium, Switzerland, Germany, Denmark, Great Britain, the Netherlands, France; South: Italy, Portugal, Spain</p></table-wrap-foot></table-wrap>
</p><p id="Par19">The association between region and in-hospital mortality stratified for frailty score is shown in Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>. After adjustment for covariates (model 2), no difference in in-hospital mortality was observed between northern and southern countries for fit and frail patients (respectively OR: 0.82; 95% CI 0.52&#x02013;1.29, and OR: 1.11; 95% CI: 0.74&#x02013;1.66). Mildly frail patients had a decreased risk on in-hospital mortality in southern compared to northern countries (OR: 0.16; 95% CI: 0.08&#x02013;0.33).</p><p id="Par20">The sensitivity analyses for the association between region and ICU admission, and region and in-hospital mortality in shown in Supplemental Table <xref rid="MOESM1" ref-type="media">1</xref>. Contrary to the primary analyses, a lower risk was observed for ICU admission and in-hospital mortality in fit patients in northern compared to southern countries (resp. OR: 0.44, 95% CI: 0.34&#x02013;0.56 and OR: 0.68; 95% CI: 0.47&#x02013;0.99). For the mildly frail and frail patients the overall pattern of results remained similar.</p></sec><sec id="Sec7"><title>Discussion</title><p id="Par21">Our study shows that despite variations in rates of ICU admissions between northern and southern countries, no difference in in-hospital mortality was observed in frail COVID-19 patients.</p><p id="Par22">Our results are in line with the scarce literature that indicates that the most severely frail patients from the northern regions are more often withheld from an ICU admission compared to the southern regions [<xref ref-type="bibr" rid="CR12">12</xref>]. Given the neutral findings regarding in-hospital mortality, our data suggests that ICU admission might not or only to a limited extent contribute to survival rates in the frailest patients (CFS 6&#x02013;9). Mildly frail patients (CFS 4&#x02013;5) had a lower risk on in-hospital mortality in the southern countries compared to the northern countries, although no difference in ICU admission was observed. The mildly frail patients may represent a subgroup that has the most potential to improve outcomes, as they are likely to have sufficient physiological reserves to recover and return to their premorbid status when provided with appropriate critical care. In addition, it is possibly difficult for clinicians to classify patients as mildly frail while fit and severely frail are less disputable. It might be hypothesized that cultural differences between north and south European countries affect classification of mildly frail patients, especially since the CFS was assigned retrospectively. In southern countries, where living together with multiple generations is more common, physicians in the Emergency Department might classify these patients as mildly frail because they are community-dwelling and therefore presumed to be functional and relatively independent [<xref ref-type="bibr" rid="CR13">13</xref>]. However, multigenerational living arrangements may mean that family members provide significant ADL and/or iADL support, potentially leading to an underestimation of frailty. Although we did not find evidence for this in the existing literature, this hypothesis warrants further investigation.</p><p id="Par23">For the interpretation of our results, we must be careful since we were not able to incorporate a disease severity scale, such as APACHE SOFA, or SAPS, in order to assess differences in disease severity between regions. Since disease severity on the ICU is related with in-hospital mortality, this could help to explain our findings [<xref ref-type="bibr" rid="CR14">14</xref>]. Nevertheless, the CFS is a patient-specific clinical judgement tool with an explicit role in triage during the pandemic. Furthermore, we were unable to collect data regarding ICU capacity among the participating centers, which possibly affected triage decisions. Moreover, the definition of an ICU bed is not standardized in Europe, and can even differ within countries. We tried to overcome this limitation by using a standardized definition from literature and excluding medium care beds from our analyses. Furthermore, the sensitivity analyses, in which the allocation of countries within regions was adjusted, showed no relevant differences in results, which strengthens our findings. Besides, in this study only patients admitted to the hospital in the first wave of the pandemic were included. More research is needed in additional waves of the pandemic to assess the effect of regional triage decisions on ICU admission and mortality.</p><p id="Par24">We conclude that this brief report provides some support to current guidelines, to not only take into account age and comorbidity burden but also frailty status before potential ICU admission. As in-hospital mortality is comparable among fit and frail patients from northern and southern regions, upholding a higher threshold for ICU admission in particularly frail patients might help optimize prioritization of resources in a pandemic setting while also offering more options for palliative care instead of ICU admission.</p></sec><sec id="Sec8" sec-type="supplementary-material"><title>Electronic supplementary material</title><p>Below is the link to the electronic supplementary material.</p><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="12879_2025_10540_MOESM1_ESM.docx"><caption><p>Supplementary Material 1</p></caption></media></supplementary-material>
</p></sec></body><back><fn-group><fn><p>The original online version of this article was revised: Following publication of the original article [1], we were notified that the names of the collaborators in the COMET research team had not been correctly tagged in the article&#x02019;s XML.</p></fn><fn><p>^ Membership of the COMET Research Team is provided in the supplemental file.</p></fn><fn><p><bold>Publisher&#x02019;s note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>Julia Minnema &#x00026; Roos Sablerolles, and Melvin Lafeber &#x00026; Miriam C. Faes contributed equally to this work.</p></fn></fn-group><ack><title>Acknowledgements</title><p>This work was supported by the LOEY Foundation and Zorg Onderzoek Nederland en Medische Wetenschappen (ZonMw) to the COVID-19 Outcomes in Older People (COOP) study (project number 10430102110005) under the COVID-19 program. The LOEY foundation and ZonMW had no role in data analysis or reporting.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>Study concept and design: JM, RS, JvK, HPB, HvK, JV, ML, MF. Acquisition of data: JM, RS, HvK, BvdL, ML, MF. Analysis and interpretation of data: JM, RS, HvK, ML, MF, MHDrafting of the manuscript: JM, RSCritical revision of the manuscript for important intellectual content: JM, RS, JvK, HvK, HPB, BvdL, JV, ML, MF, MH.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This work was supported by the LOEY Foundation and by ZonMw (Zorg Onderzoek Nederland en Medische Wetenschappen): Grant 10430102110005.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>The individual, de-identified patient data that underlie the results reported in this short report (text and table) are available on reasonable request from the corresponding author (Julia Minnema) under certain conditions (with the consent of all participating centers and with a signed data access agreement).</p></notes><notes><title>Declarations</title><notes id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par25">The institutional review committee of the main site, Erasmus MC in Rotterdam, the Netherlands, approved the study (MEC-2020-0277), and each institutional review board of the participating hospitals approved the use of data, as described in the protocol [<xref ref-type="bibr" rid="CR8">8</xref>]. Written informed consent was not required, since this study is no subject to the Medical Research Involving Human Subjects Act (WMO) and only limited data was collected which followed routine practice. All data were treated according to the European privacy regulations and the study was performed in accordance with the declaration of Helsinki.</p></notes><notes id="FPar2"><title>Consent for publication</title><p id="Par26">Not applicable.</p></notes><notes id="FPar3" notes-type="COI-statement"><title>Competing interests</title><p id="Par27">The authors declare no competing interests.</p></notes></notes><glossary><title>Abbreviations</title><def-list><def-item><term>ICU</term><def><p id="Par28">Intensive Care Unit</p></def></def-item><def-item><term>CFS</term><def><p id="Par29">Clinical Frailty Scale</p></def></def-item><def-item><term>SARS-CoV-2</term><def><p id="Par30">Severe Acute Respiratory Syndrome COronaVirus 2</p></def></def-item><def-item><term>COMET</term><def><p id="Par31">COvid MEdicaTion study</p></def></def-item><def-item><term>OR</term><def><p id="Par32">Odds Ratio</p></def></def-item><def-item><term>CI</term><def><p id="Par33">Confidence Interval</p></def></def-item></def-list></glossary><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Tyrrell</surname><given-names>CSB</given-names></name><name><surname>Mytton</surname><given-names>OT</given-names></name><name><surname>Gentry</surname><given-names>SV</given-names></name><name><surname>Thomas-Meyer</surname><given-names>M</given-names></name><name><surname>Allen</surname><given-names>JLY</given-names></name><name><surname>Narula</surname><given-names>AA</given-names></name><etal/></person-group><article-title>Managing intensive care admissions when there are not enough beds during the COVID-19 pandemic: a systematic review</article-title><source>Thorax</source><year>2021</year><volume>76</volume><issue>3</issue><fpage>302</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1136/thoraxjnl-2020-215518</pub-id><pub-id pub-id-type="pmid">33334908</pub-id>
</element-citation><mixed-citation id="mc-CR1" publication-type="journal">Tyrrell CSB, Mytton OT, Gentry SV, Thomas-Meyer M, Allen JLY, Narula AA, et al. Managing intensive care admissions when there are not enough beds during the COVID-19 pandemic: a systematic review. Thorax. 2021;76(3):302&#x02013;12.<pub-id pub-id-type="pmid">33334908</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Abma</surname><given-names>IL</given-names></name><name><surname>Olthuis</surname><given-names>GJ</given-names></name><name><surname>Oerlemans</surname><given-names>AJM</given-names></name></person-group><article-title>Comparing the Dutch ICU triage guidelines to guidelines from abroad: differences and similarities</article-title><source>Neth J Crit Care</source><year>2021</year><volume>29</volume><fpage>238</fpage><lpage>45</lpage></element-citation><mixed-citation id="mc-CR2" publication-type="journal">Abma IL, Olthuis GJ, Oerlemans AJM. Comparing the Dutch ICU triage guidelines to guidelines from abroad: differences and similarities. Neth J Crit Care. 2021;29:238&#x02013;45.</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>J&#x000f6;bges</surname><given-names>S</given-names></name><name><surname>Vinay</surname><given-names>R</given-names></name><name><surname>VA Luyckx</surname></name><name><surname>N Biller-Andorno</surname></name></person-group><article-title>Recommendations on COVID-19 triage: international comparison and ethical analysis</article-title><source>Bioethics</source><year>2020</year><volume>34</volume><fpage>948</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1111/bioe.12805</pub-id><pub-id pub-id-type="pmid">32975826</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">J&#x000f6;bges S, Vinay R, VA Luyckx, N Biller-Andorno. Recommendations on COVID-19 triage: international comparison and ethical analysis. Bioethics. 2020;34:948&#x02013;59.<pub-id pub-id-type="pmid">32975826</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Avidan</surname><given-names>A</given-names></name><name><surname>Sprung</surname><given-names>CL</given-names></name><name><surname>Schefold</surname><given-names>JC</given-names></name><name><surname>Ricou</surname><given-names>B</given-names></name><name><surname>Hartog</surname><given-names>CS</given-names></name><name><surname>Nates</surname><given-names>JL</given-names></name><etal/></person-group><article-title>Variations in end-of-life practices in intensive care units worldwide (Ethicus-2): a prospective observational study</article-title><source>Lancet Respiratory Med</source><year>2021</year><volume>9</volume><issue>10</issue><fpage>1101</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1016/S2213-2600(21)00261-7</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">Avidan A, Sprung CL, Schefold JC, Ricou B, Hartog CS, Nates JL, et al. Variations in end-of-life practices in intensive care units worldwide (Ethicus-2): a prospective observational study. Lancet Respiratory Med. 2021;9(10):1101&#x02013;10.</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Wernly</surname><given-names>B</given-names></name><name><surname>Rezar</surname><given-names>R</given-names></name><name><surname>Flaatten</surname><given-names>H</given-names></name><name><surname>Beil</surname><given-names>M</given-names></name><name><surname>Fj&#x000f8;lner</surname><given-names>J</given-names></name><name><surname>Bruno</surname><given-names>RR</given-names></name><etal/></person-group><article-title>Variations in end-of&#x02010;life care practices in older critically ill patients with COVID&#x02010;19 in Europe</article-title><source>J Intern Med</source><year>2022</year><volume>292</volume><issue>3</issue><fpage>438</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1111/joim.13492</pub-id><pub-id pub-id-type="pmid">35398948</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">Wernly B, Rezar R, Flaatten H, Beil M, Fj&#x000f8;lner J, Bruno RR, et al. Variations in end-of&#x02010;life care practices in older critically ill patients with COVID&#x02010;19 in Europe. J Intern Med. 2022;292(3):438&#x02013;49.<pub-id pub-id-type="pmid">35398948</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Searle</surname><given-names>SD</given-names></name><name><surname>Rockwood</surname><given-names>K</given-names></name></person-group><article-title>Does determining the degree of frailty help pandemic decision-making when resources are scarce?</article-title><source>Lancet Healthy Longev</source><year>2021</year><volume>2</volume><issue>3</issue><fpage>e119</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/S2666-7568(21)00030-1</pub-id><pub-id pub-id-type="pmid">33817683</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">Searle SD, Rockwood K. Does determining the degree of frailty help pandemic decision-making when resources are scarce? Lancet Healthy Longev. 2021;2(3):e119&#x02013;20.<pub-id pub-id-type="pmid">33817683</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Rockwood</surname><given-names>K</given-names></name><name><surname>Theou</surname><given-names>O</given-names></name></person-group><article-title>Using the clinical frailty scale in allocating scarce health care resources</article-title><source>Can Geriatr J</source><year>2020</year><volume>23</volume><issue>3</issue><fpage>210</fpage><pub-id pub-id-type="doi">10.5770/cgj.23.463</pub-id><pub-id pub-id-type="pmid">32904824</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Rockwood K, Theou O. Using the clinical frailty scale in allocating scarce health care resources. Can Geriatr J. 2020;23(3):210.<pub-id pub-id-type="pmid">32904824</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Sablerolles</surname><given-names>RSG</given-names></name><name><surname>Hogenhuis</surname><given-names>FEF</given-names></name><name><surname>Lafeber</surname><given-names>M</given-names></name><name><surname>Van De Loo</surname><given-names>BPA</given-names></name><name><surname>Borgsteede</surname><given-names>SD</given-names></name><name><surname>Boersma</surname><given-names>E</given-names></name><etal/></person-group><article-title>COvid MEdicaTion (COMET) study: protocol for a cohort study</article-title><source>Eur J Hosp Pharm</source><year>2020</year><volume>27</volume><issue>4</issue><fpage>191</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1136/ejhpharm-2020-002329</pub-id><pub-id pub-id-type="pmid">32587077</pub-id>
</element-citation><mixed-citation id="mc-CR8" publication-type="journal">Sablerolles RSG, Hogenhuis FEF, Lafeber M, Van De Loo BPA, Borgsteede SD, Boersma E, et al. COvid MEdicaTion (COMET) study: protocol for a cohort study. Eur J Hosp Pharm. 2020;27(4):191&#x02013;3.<pub-id pub-id-type="pmid">32587077</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Sablerolles</surname><given-names>RSG</given-names></name><name><surname>Lafeber</surname><given-names>M</given-names></name><name><surname>van Kempen</surname><given-names>JAL</given-names></name><name><surname>van de Loo</surname><given-names>BPA</given-names></name><name><surname>Boersma</surname><given-names>E</given-names></name><name><surname>Rietdijk</surname><given-names>WJR</given-names></name><etal/></person-group><article-title>Association between Clinical Frailty Scale score and hospital mortality in adult patients with COVID-19 (COMET): an international, multicentre, retrospective, observational cohort study</article-title><source>Lancet Healthy Longev</source><year>2021</year><volume>2</volume><issue>3</issue><fpage>e163</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1016/S2666-7568(21)00006-4</pub-id><pub-id pub-id-type="pmid">33655235</pub-id>
</element-citation><mixed-citation id="mc-CR9" publication-type="journal">Sablerolles RSG, Lafeber M, van Kempen JAL, van de Loo BPA, Boersma E, Rietdijk WJR, et al. Association between Clinical Frailty Scale score and hospital mortality in adult patients with COVID-19 (COMET): an international, multicentre, retrospective, observational cohort study. Lancet Healthy Longev. 2021;2(3):e163&#x02013;70.<pub-id pub-id-type="pmid">33655235</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Sprung</surname><given-names>CL</given-names></name><name><surname>Cohen</surname><given-names>SL</given-names></name><name><surname>Sjokvist</surname><given-names>P</given-names></name><name><surname>Baras</surname><given-names>M</given-names></name><name><surname>Bulow</surname><given-names>H-H</given-names></name><name><surname>Hovilehto</surname><given-names>S</given-names></name><etal/></person-group><article-title>End-of-life practices in European intensive care units: the Ethicus Study</article-title><source>JAMA</source><year>2003</year><volume>290</volume><issue>6</issue><fpage>790</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1001/jama.290.6.790</pub-id><pub-id pub-id-type="pmid">12915432</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Sprung CL, Cohen SL, Sjokvist P, Baras M, Bulow H-H, Hovilehto S, et al. End-of-life practices in European intensive care units: the Ethicus Study. JAMA. 2003;290(6):790&#x02013;7.<pub-id pub-id-type="pmid">12915432</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><mixed-citation publication-type="other">Society IC. GUIDELINES FOR THE PROVISION OF INTENSIVE CARE SERVICES. 2022.</mixed-citation></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Guidet</surname><given-names>B</given-names></name><name><surname>Flaatten</surname><given-names>H</given-names></name><name><surname>Boumendil</surname><given-names>A</given-names></name><name><surname>Morandi</surname><given-names>A</given-names></name><name><surname>Andersen</surname><given-names>FH</given-names></name><name><surname>Artigas</surname><given-names>A</given-names></name><etal/></person-group><article-title>Withholding or withdrawing of life-sustaining therapy in older adults (&#x0003e;/= 80 years) admitted to the intensive care unit</article-title><source>Intensive Care Med</source><year>2018</year><volume>44</volume><issue>7</issue><fpage>1027</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1007/s00134-018-5196-7</pub-id><pub-id pub-id-type="pmid">29774388</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Guidet B, Flaatten H, Boumendil A, Morandi A, Andersen FH, Artigas A, et al. Withholding or withdrawing of life-sustaining therapy in older adults (&#x0003e;/= 80 years) admitted to the intensive care unit. Intensive Care Med. 2018;44(7):1027&#x02013;38.<pub-id pub-id-type="pmid">29774388</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="other">Liu C, Esteve A. Living arrangements across households in Europe. Research Handbook on the sociology of the family. Edward Elgar Publishing; 2021. pp. 187&#x02013;204.</mixed-citation></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Le Gall</surname><given-names>J-R</given-names></name></person-group><article-title>The use of severity scores in the intensive care unit</article-title><source>Intensive Care Med</source><year>2005</year><volume>31</volume><fpage>1618</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1007/s00134-005-2825-8</pub-id><pub-id pub-id-type="pmid">16244878</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Le Gall J-R. The use of severity scores in the intensive care unit. Intensive Care Med. 2005;31:1618&#x02013;23.<pub-id pub-id-type="pmid">16244878</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>